Upsher Smith Laboratories, Inc. recalls Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple G…
- Recall date
- July 29, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1836-2019
- FDA classification
- Class II
- Brand / firm
- Upsher Smith Laboratories, Inc.
- Sold / distributed
- KY, OH, NJ, LA
Why it was recalled
Failed Dissolution Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple Grove, MN 55369. NDC: 0832-0285-00
Get recall alerts
Free email alert whenever Upsher Smith Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Upsher Smith Laboratories, Inc.